메뉴 건너뛰기
Journal of Association of Physicians of India
Volumn 46, Issue 9, 1998, Pages 827-828
Early experience with sparfloxacin in tuberculosis
Author keywords

[No Author keywords available]
Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SPARFLOXACIN; TUBERCULOSTATIC AGENT;
EID: 0032149114     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)
References (10)
  • 1
    • 0014511674 scopus 로고
    • Second drug resistance investigation
    • Indian Council of Medical Research. Second drug resistance investigation. Ind J Med Res 1969; 57 : 823-35.
    • (1969) Ind J Med Res , vol.57 , pp. 823-835
  • 2
    • 0023865401 scopus 로고
    • Primary anti-tuberculosis drug resistance and acquired Rifampicin resistance in Gujarat. India
    • Trivedi SS, Desai SG. Primary anti-tuberculosis drug resistance and acquired Rifampicin resistance in Gujarat. India. Tubercle 1988; 69 : 37-42.
    • (1988) Tubercle , vol.69 , pp. 37-42
    • Trivedi, S.S.1    Desai, S.G.2
  • 3
    • 0027462030 scopus 로고
    • Bacteriological investigations for short course chemotherapy under the tuberculosis program in two districts of India
    • Paramasivan CN, Chandrasekaran V, Santa T, Sundrasanam NM, Prabhakar R. Bacteriological investigations for short course chemotherapy under the tuberculosis program in two districts of India. Tubercle Lung Dis 1993; 74 : 23-7.
    • (1993) Tubercle Lung Dis , vol.74 , pp. 23-27
    • Paramasivan, C.N.1    Chandrasekaran, V.2    Santa, T.3    Sundrasanam, N.M.4    Prabhakar, R.5
  • 4
    • 2542572929 scopus 로고
    • A study of efficacy and toxicity of short course chemotherapy with ERZH in Pulmonary Tuberculosis
    • Dubey GR, Shah RC, Kamat SR. et al A study of efficacy and toxicity of short course chemotherapy with ERZH in Pulmonary Tuberculosis. Lung India 1985; 3 : 115-122.
    • (1985) Lung India , vol.3 , pp. 115-122
    • Dubey, G.R.1    Shah, R.C.2    Kamat, S.R.3
  • 5
    • 2542615646 scopus 로고    scopus 로고
    • Sparfloxacin
    • Scientific Product Monograph
    • Sparfloxacin. Scientific Product Monograph. Ranbaxy Lab 1996; 7.
    • (1996) Ranbaxy Lab , pp. 7
  • 6
    • 0020537408 scopus 로고
    • Madras Study of Chemotherapy regimens of five and seven months duration and the role of corticoids in the treatment of sputum positive patients with pulmonary tuberculosis in South India
    • Tuberculosis Research Centre, Madras Study of Chemotherapy regimens of five and seven months duration and the role of corticoids in the treatment of sputum positive patients with pulmonary tuberculosis in South India. Tubercle 1983; 64: 73-91.
    • (1983) Tubercle , vol.64 , pp. 73-91
  • 7
    • 0026729017 scopus 로고
    • Drug treatment of tuberculosis
    • Davidson PT, Quoc Le H. Drug treatment of tuberculosis. Drugs 1992; 43 : 651-73.
    • (1992) Drugs , vol.43 , pp. 651-673
    • Davidson, P.T.1    Quoc Le, H.2
  • 8
    • 0022254848 scopus 로고
    • Mechanisms of drug action in short course chemotherapy
    • Mitchison DA. Mechanisms of drug action in short course chemotherapy. Bull IUAT 1985; 60 : 34-7.
    • (1985) Bull IUAT , vol.60 , pp. 34-37
    • Mitchison, D.A.1
  • 9
    • 0028805058 scopus 로고
    • New drugs for tuberculosis
    • Grass C, Peona V. New drugs for tuberculosis. Eur Resp J(Suppl) 1995; 20: 714-8.
    • (1995) Eur Resp J(Suppl) , vol.20 , pp. 714-718
    • Grass, C.1    Peona, V.2
  • 10
    • 0002390930 scopus 로고
    • Use of sparfloxacin for the treatment of MDR pulmonary tuberculosis
    • Schaberg T, Specht C, Stephen H, Lode H. Use of sparfloxacin for the treatment of MDR pulmonary tuberculosis. Tubercle Lung Dis 1995; 76 (Suppl 2) : 86.
    • (1995) Tubercle Lung Dis , vol.76 , Issue.2 SUPPL. , pp. 86
    • Schaberg, T.1    Specht, C.2    Stephen, H.3    Lode, H.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.